1999
DOI: 10.1056/nejm199901073400102
|View full text |Cite|
|
Sign up to set email alerts
|

Increased Frequency of Genetic Thrombophilia in Women with Complications of Pregnancy

Abstract: Women with serious obstetrical complications have an increased incidence of mutations predisposing them to thrombosis and other inherited and acquired forms of thrombophilia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

28
509
8
41

Year Published

1999
1999
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 1,006 publications
(590 citation statements)
references
References 31 publications
28
509
8
41
Order By: Relevance
“…We found no differences m the prevalence of inherited nsk factors for venous thrombosis, mcluding factor V Leiden, prothrombm 20210A allele, and protem C, protem S, and antithrombin deficiencies, m women who had preeclampsia m their first pregnancy and in control subjects with an uneventful pregnancy This is in contrast with data from previous published studies 6 16,17 One explanation is the unexpectedly high frequency of factor V Leiden in the control group (9 2%) in this study We therefore compared the frequency of the factor V Leiden mutation among women who had preeclampsia with that of a different control group exammed previously 18 This group consisted of a subset of the original control group of the Leiden Thrombophilia Study In that study 474 consecutive patients with thrombosis were matched with 474 control subjects who either were acquamtances asked to participate by the patients or were partners of the patients From these control groups we selected, for the current analysis, women who had expenenced at least l pregnancy, had no history of venous thrombosis, were premenopausal, were not pregnant, were not in the puerperium, and had no recent miscarriäge (total women included, 105) 18 We found a higher frequency for factor V Leiden m women who had preeclampsia versus these control subjects (odds ratio, 3 70, 95% confidence interval, l 05 13 03) When we compare the frequency of the prothrombm 2021 OA allele among women who had preeclampsia with that of the same alternative control groupi 8 (total women included, 105, prothrombm 20210A allele positive, 3), no differences m frequency were found for prothrombm 20210A allele (odds ratio, l 08, 95% confidence interval, 0 25 4 60) DizonTownson et al 16 reported a frequency of factor V Leiden in an American obstetric populaüon of 4 2% (n = 403), which is similar to the frequency described m the Leiden Thrombophilia Study and a large Amencan study (3% 4%)''' and almost 3 times lower than the frequency obser\ed in the control subjects recruited m our studv Di/on-Townson et al l() also reported a frequency of factoi \ I eiden of 3% m an unselected group of gravid women Ho\\e\ei higher hequenciei o( factoi V Leiden have also Volume 181, Number 4 AmJ Obstet Gynecol DeGrootetal 979 been described by Pauer et al 21 ; frequencies of 9.2% (8/87 of an unselected group of healthy women with no history of fetal losses) and äs high äs 12% have been reported in some selected groups with a history of venous thrombosis or pulmonary embolism. 22 If the high frequency of factor V Leiden was too high in our control group, we can speculate about selection bias.…”
Section: Commentcontrasting
confidence: 99%
See 1 more Smart Citation
“…We found no differences m the prevalence of inherited nsk factors for venous thrombosis, mcluding factor V Leiden, prothrombm 20210A allele, and protem C, protem S, and antithrombin deficiencies, m women who had preeclampsia m their first pregnancy and in control subjects with an uneventful pregnancy This is in contrast with data from previous published studies 6 16,17 One explanation is the unexpectedly high frequency of factor V Leiden in the control group (9 2%) in this study We therefore compared the frequency of the factor V Leiden mutation among women who had preeclampsia with that of a different control group exammed previously 18 This group consisted of a subset of the original control group of the Leiden Thrombophilia Study In that study 474 consecutive patients with thrombosis were matched with 474 control subjects who either were acquamtances asked to participate by the patients or were partners of the patients From these control groups we selected, for the current analysis, women who had expenenced at least l pregnancy, had no history of venous thrombosis, were premenopausal, were not pregnant, were not in the puerperium, and had no recent miscarriäge (total women included, 105) 18 We found a higher frequency for factor V Leiden m women who had preeclampsia versus these control subjects (odds ratio, 3 70, 95% confidence interval, l 05 13 03) When we compare the frequency of the prothrombm 2021 OA allele among women who had preeclampsia with that of the same alternative control groupi 8 (total women included, 105, prothrombm 20210A allele positive, 3), no differences m frequency were found for prothrombm 20210A allele (odds ratio, l 08, 95% confidence interval, 0 25 4 60) DizonTownson et al 16 reported a frequency of factor V Leiden in an American obstetric populaüon of 4 2% (n = 403), which is similar to the frequency described m the Leiden Thrombophilia Study and a large Amencan study (3% 4%)''' and almost 3 times lower than the frequency obser\ed in the control subjects recruited m our studv Di/on-Townson et al l() also reported a frequency of factoi \ I eiden of 3% m an unselected group of gravid women Ho\\e\ei higher hequenciei o( factoi V Leiden have also Volume 181, Number 4 AmJ Obstet Gynecol DeGrootetal 979 been described by Pauer et al 21 ; frequencies of 9.2% (8/87 of an unselected group of healthy women with no history of fetal losses) and äs high äs 12% have been reported in some selected groups with a history of venous thrombosis or pulmonary embolism. 22 If the high frequency of factor V Leiden was too high in our control group, we can speculate about selection bias.…”
Section: Commentcontrasting
confidence: 99%
“…However, Dizon-Townson et al 16 described a frequency of factor V Leiden that was similar to that found in our study (n = 158, 8.9%) in women with severe preeclampsia. Recently, Kupfermine et al 6 reported a prevalence of 53% of inherited thrombophilia in women with severe preeclampsia, including 26% (9/34) with factor V Leiden. Furthermore, it is unlikely that our results are explained by the geography of our population because the frequency of factor V Leiden was similar in the population of 2 different hospitals from 2 different regions of the country.…”
Section: Commentmentioning
confidence: 99%
“…It has been demonstrated that one of the risk factors in the pregnant women for PE is hyperhomocysteinemia, which can result in endothelial dysfunction and increase oxidative stress. Numerous studies have demonstrated a direct relationship between hyperhomocysteinemia and PE [73][74][75][76][77][78][79][80] . Leeda et al 81 found the same incidence of hyperhomocysteinemia in preeclamptic patients as Dekker et al (17.7%) 74 .…”
Section: Hyperhomocysteine and Preeclampsiamentioning
confidence: 99%
“…Тром-бофилия, согласно литературным данным, имеет высокую степень корреляции с осложнениями бере-менности: спонтанные аборты, привычное невына-шивание, отслойка плаценты, неразвивающаяся бере-менность, преждевременные роды, внутриутробная задержка роста плода, преэклампсия [6][7][8][9].…”
Section: Introductionunclassified